2020台灣生技月 Bio Taiwan 生物科技大展

2020 台灣生技月 南港展覽館

講師

SPARK Program at Monash University, Australia

Personalised aerosol drug delivery: tuning particle size on-demand

Future Company Type

Device, Diagnostics

Prestartup

Expecting startup year /2020

No. of team members /5

Stage

Development

Presenter

Name /Jason Brenker

Title /Dr.

Email /Jason.brenker@monash.edu

Telephone /(Work) +61 431196889

Fax /

Mobile /+61 431196889

About the Team

We are an interdisciplinary team, which brings together expertise in engineering, design, pharmacy and respiratory medicine from three different institutions (Monash University, University of Sydney and Swinburne University).

The core team combines expertise in microfluidic droplet ejection, nanofabrication (Jason Brenker & Tuncay Alan) and respiratory drug delivery, in vitro studies and repurposing (Daniela Traini), biologicals and respiratory models (Hui Xin Ong), immunology and respiratory medicine (Bruce Thompson), and industrial design (Daphne Flynn). We have a state- of- the- art laboratory and with access to specialised instrumentation for the optimisation of the microfluidic components and device integration and pharmaceutical characterisation.

Brief Description of main products or services

PALM (Personalised Aerosol Loading and Management) Breather is a portable aerosol drug delivery platform. It employs a small form-factor device, which sits comfortably in the palm of the hand, and fits a variety of face shapes thanks to its universal design (design registration pending). The device uses disposable microfluidic chips to dial the size, distribution and dose of aerosolised particles on-demand. This represents a first for targeted, personalised inhalation therapy that is tuneable for pulmonary and nasal administration of therapeutics from a single device. A PCT patent application (PCT/AU2019/050778) was recently filed in the name of Monash University. We have a portable integrated aerosol system, which can address the specific needs of patients, for the specific delivery route. We are currently gathering pre-clinical data from our prototypes and progressing towards commercialization with the aim of beginning clinical trials within the next year.

Contact Person

Name /Jason Brenker & Tuncay Alan

Phone /+61 3 990 53709

Email /Jason.brenker@monash.edu, tuncay.alan@monash.edu